- Northrop Grumman recently supported NASA’s crewed Artemis II launch with its five‑segment solid rocket boosters and showcased its modular, autonomous Lumberjack drone in a U.S. Army exercise, underscoring its role across space and defense missions.
- These advances in crewed spaceflight hardware and expendable uncrewed systems highlight how Northrop Grumman is aligning its capabilities with evolving military and space‑exploration priorities.
- Now we’ll examine how Northrop Grumman’s Lumberjack autonomous drone progress could influence its investment narrative and expectations for future programs.
We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
Northrop Grumman Investment Narrative Recap
To own Northrop Grumman, you need to be comfortable with a defense and space contractor whose fortunes are closely tied to large, long‑cycle U.S. government programs. The Artemis II booster success and Lumberjack drone trials support the near term catalyst of expanding roles in space and autonomous systems, but do not materially change the key risk that any shift in U.S. budget priorities or major program adjustments could affect revenue visibility.
Among recent developments, Wells Fargo’s initiation of coverage with an "Overweight" rating and an US$800 price target is most relevant here, because it reflects how at least one large institution is framing Northrop Grumman’s diversified exposure to areas like solid rocket motors and uncrewed systems. That external interest sits alongside the company’s own investments in autonomy and space, which many investors watch as potential contributors to future orders and margins.
Yet against this backdrop, investors also need to be aware of how dependent Northrop Grumman remains on a handful of very large U.S. programs...
Read the full narrative on Northrop Grumman (it's free!)
Northrop Grumman's narrative projects $49.0 billion revenue and $4.5 billion earnings by 2029. This requires 5.3% yearly revenue growth and about a $0.3 billion earnings increase from $4.2 billion today.
Uncover how Northrop Grumman's forecasts yield a $725.72 fair value, a 4% upside to its current price.
Exploring Other Perspectives
Three members of the Simply Wall St Community currently see Northrop Grumman’s fair value between US$534.92 and US$733.24, highlighting a wide spread of expectations. You may want to weigh those views against the ongoing risk that changes in U.S. defense budgets or big program decisions could alter the company’s long term earnings profile.
Explore 3 other fair value estimates on Northrop Grumman - why the stock might be worth 23% less than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Northrop Grumman research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Northrop Grumman research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Northrop Grumman's overall financial health at a glance.
Want Some Alternatives?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- This technology could replace computers: discover 23 stocks that are working to make quantum computing a reality.
- Invest in the nuclear renaissance through our list of 93 elite nuclear energy infrastructure plays powering the global AI revolution.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 21 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com